Status:
COMPLETED
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
Lead Sponsor:
Heidelberg University
Conditions:
Brain Infarction
Cerebral Ischemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Treatment of acute stroke is still difficult and the only specific drug approved (rtPA) can only be administered if treatment starts within 3 hours after onset of symptoms. This results in a still too...
Eligibility Criteria
Inclusion
- 18 years and above, both sexes
- Acute ischemic stroke with first symptoms within 6 hours of beginning
- Treatment after onset of symptoms
- SSS \< 40 at baseline ( consciousness necessary )
Exclusion
- Clinical or CT evidence of brain hemorrhage or hemorrhagic transformation
- CT evidence of major signs of developing infarction
- Coma
- Prior strokes within 6 weeks
- Severe hypertension (\> 220 systolic \> 120 mm Hg diastolic)
- Baseline fibrinogen \< 100 mg/dL
- Recent use of thrombolytic agents
- Recent or anticipated surgery
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00343174
Last Update
June 22 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.